Pfizer phase 3 INTORACT trial fails to meet endpoint
The trial reportedly did not meet its primary endpoint of superiority in extending progression free survival (PFS). Pfizer Oncology Business Unit senior vice president of clinical development and
The trial reportedly did not meet its primary endpoint of superiority in extending progression free survival (PFS). Pfizer Oncology Business Unit senior vice president of clinical development and
MCT-465 and MCT-485 are cancer therapeutics, which use TLR3 signaling technology. During the trials, MCT-485 showed in vitro dose-effect cytotoxicity on several human hepatocellular carcinoma cell lines while
The grant, in addition to Phase I SBIR grant, will support a collaborative research effort between ADi and Sanaria to use ADi’s proteome microarrays to identify biomarkers associated
AVAglio Phase III is a randomized, double-blind, placebo controlled trial that has assessed the efficacy and safety profile of Avastin in combination with radiation and temozolomide chemotherapy. In
The JV will develop OTC products line, which includes skin creams, nutraceutical and cosmetic products for the international markets. Cannabis Science president and CEO Robert Melamede said Cannabis
Modafinil USP,100 mg and 200 mg tablets are generic equivalent to Cephalon’s Provigil tablets and are indicated to improve wakefulness in adult patients with excessive sleepiness associated with
Lucentis 0.3 mg is a recombinant humanized monoclonal antibody fragment (lacking an Fc region), designed to treat diabetic macular edema (DME). The approval of Lucentis in DME was
The Company is planning to enrol 18 Fabry disease patients for a phase I/II trial in the fourth quarter of 2012. As part of the trial, the enrolled
Marqibo, a sphingomyelin/cholesterol liposome-encapsulated formulation of vincristine sulfate, is administered at a dose of 2.25 mg/m2 intravenously over 1 hour once every 7 days. Marqibo is intended for
Based on the achievement of pre-determined milestones, the company will receive $1.5m in funding for the first of five years. In addition, DARPA is funding for the development